›› 2019, Vol. 39 ›› Issue (9): 991-.doi: 10.3969/j.issn.1674-8115.2019.09.009

• Original article (Basic research) • Previous Articles     Next Articles

Effect of the PI3K/AKT signaling pathway regulatedHMGCS1 on drug sensitivity of HL-60 cells

JIA Yan1,2, WANG Hui-wen1, YI Jin-mou1, ZENG Hui2, LU Min3   

  1. 1. Department of Hematology, Xiangya Hospital, Central South University, Changsha 410008, China; 2. Department of Hematology, The First Affiliated Hospital of Jinan University, Guangzhou 510630, China; 3. Shanghai Institute of Hematology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China
  • Online:2019-09-28 Published:2019-11-02
  • Supported by:
    National Natural Science Foundation of China, 81770184; Shanghai Municipal Education Commission— Gaofeng Clinical Medicine Support, 20161305)。

Abstract: Objective · To explore the mechanism of 3-hydroxymethyl-3-methylglutaryl-CoA synthase 1 (HMGCS1) on drug sensitivity of acute myelocytic leukemia (AML) HL-60 cells. Methods · HL-60 cells were cultured. The negative control group and the HMGCS1 overexpressed group were constructedinfecting the negative control lentivirus and HMGCS1 lentivirus, and the untreated HL-60 cells were set as the blank control group. Real-time quantitative PCR (qPCR) was used to detect the of HMGCS1 mRNA in the 3 groups, and to verify whether the cell lines of the HMGCS1 overexpressed group were successfully constructed. The effect of HMGCS1 on the of AKT and phosphorylated AKT (p-AKT) in phosphatidylinositol 3 kinase (PI3K) / protein kinase B (PKB / AKT) signaling pathway was detectedWestern blotting. CCK8 method was used to detect the effects of HMGCS1 and PI3K/AKT signaling pathway inhibitor LY29400 on the activity of HL-60 cells. The effect of LY29400 on HMGCS1 was detectedqPCR and Western blotting. Results · Compared with the negative control group, the HMGCS1 mRNA was increased significantly in the HMGCS1 overexpressed group (P0.000). Compared with the blank control group and the negative control group, the p-AKT protein level in the HMGCS1 over group was significantly increased, while the AKT of the 3 groups was not significantly different. CCK8 method showed that compared with the blank control group and the negative control group, HMGCS1 could reduce the effect of adriamycin on cell viability in the HMGCS1 overexpressed group (P0.003, P0.006), while LY294002 could inhibit the effect producedHMGCS1 (P0.000). The intervention of LY294002 could reduce the levels of HMGCS1 and p-AKT protein and HMGCS1 mRNA (both P0.000) in the negative control group and the blank control group. Conclusion · HMGCS1 can reduce the sensitivity of HL-60 cells to chemotherapy drug adriamycin, while PI3K/AKT signaling pathway inhibitor LY294002 can restore its sensitivity.

Key words: 3-hydroxymethyl-3-methylglutaryl-CoA synthase 1 (HMGCS1), cholesterol metabolism, phosphatidylinositol 3 kinase (PI3K) / protein

CLC Number: